JP Morgan
Bregal Milestone prepares Epassi exit via JP Morgan
Bregal Milestone has held a majority stake in the Finnish employee benefit platform since 2019
BC's VetPartners sees Blackstone, KKR, Partners Group among parties preparing bids
Veterinary group could fetch a valuation in the GBP 2.5bn-GBP 3bn region, having been acquired by BC in 2018
Bridgepoint appoints advisers for Qualitest sale
JPMorgan and Jefferies will advise on an auction for the software testing group
Jewson carve-out sees Apollo, CVC, HIG, TDR in round two
Final bids for Saint-Gobain's building materials unit are due at the end of this month
Stirling Square cancels Outcomes First Group sale process
GP expected to switch focus to break-up of UK specialist care and fostering provider
IFF carve-out of Frutarom Savory likely to attract large sponsors
JPMorgan and Lazard will lead on the auction of Austrian food ingredients subsidiary, which could launch as early as June
Altor in early dual-track preparations to exit Transcom
Rothschild is mandated as sale adviser for the Swedish BPO group, while JP Morgan will advise on IPO track
Motive sells Global Shares to JP Morgan
Deal generates around 10x return on invested capital and values the Irish equity compensation software solutions at USD 750m EV
Cinven picks dual-track exit advisers for Envirotainer
Citi, JP Morgan and Carnegie are among banks advising on the upcoming exit of the Swedish temperature-controlled air cargo containers group
Vitruvian's Bitdefender hires advisers for IPO-led exit
Romanian cybersecurity company appoints JP Morgan and Morgan Stanley for a dual-track process
Tikehau's SPAC Pegasus raises €500m
Tikehau, Financière Agache, Jean-Pierre Mustier and Diego De Giorgi commit to invest a total amount in excess of €165m
CapVest sells Eight Fifty to Sofina Foods
Combined group is expected to employ 13,000 staff across 44 sites and generate $6bn in annual revenues
VC-backed Auto1 announces IPO pricing
IPO of the used-car trading platform is expected on the Frankfurt Stock Exchange on 4 February 2021
Nordic Capital launches $2bn take-over for Advanz
Advanz Pharma initially hired Jefferies to advise on a sale process in October 2020
Carlyle to explore sale options for Hunkemöller – report
GP had explored IPO options for the Netherlands-headquartered lingerie and loungewear chain in 2018
The Deals Pipeline
A highlight of deal processes underway and involving PE, either on the buy- or sell-side, across Europe
Bridgepoint-backed Diaverum plans IPO in November – reports
Transaction could reportedly value the company at more than €2bn
Dawn leads $20m series-B for Access Fintech
Existing investors JP Morgan, Citi and Goldman Sachs contribute to the latest round
EQT carves out Natural Colours from Chr Hansen in €800m deal
GP is deploying equity from its latest fund, EQT IX, which will be 15-20% invested following deal completion
BlackRock-backed THG to launch £920m IPO
Following the listing, the online retailer will have a free float of at least 20%
BC Partners backs Ima in €3.6bn deal
BC Partners and Sofima will launch a mandatory tender offer to acquire all remaining Ima shares
Bridgepoint sells Rovensa to Partners Group in €1bn deal
Sale ends a four-year holding period for Bridgepoint, which bought Rovensa from Sapec Group
Altor acquires 30% stake in renewable energy company OX2
GP is deploying capital from its €2.5bn fund, which is understood to have made four investments so far
Goldman Sachs et al. back $27m round for H4
Barclays Ventures, JP Morgan and Linklaters also invest in the digital documentation firm
Most read
